• SD Biotechnologies will hold an extraordinary shareholders’ meeting in Seoul on Oct. 15, 2026.
• Shareholders will vote on amendments to the articles of incorporation to raise par value per common share to 1,000 won from 200 won.
• The meeting will also consider a 5-for-1 reverse stock split, cutting common shares outstanding to 21,946,628 from 109,733,141.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SD Biotechnologies Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260930000406), on September 30, 2026, and is solely responsible for the information contained therein.